المؤلفون: Jia Yin (287896), Chao-Ling Wan (11381922), Ling Zhang (18071), Hao Zhang (15339), Lian Bai (2663473), Hai-Xia Zhou (11381925), Ming-Zhu Xu (11381928), Li-Yun Chen (5368859), Chong-Sheng Qian (11381931), Hui-Ying Qiu (11381934), Su-Ning Chen (11381937), Xiao-Wen Tang (8601642), De-Pei Wu (3686050), Yan-Ming Zhang (9145534), Ai-Ning Sun (11381940), Sheng-Li Xue (11381943)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, epigenomics, histone deacetylase inhibitor (HDACi), CDIAG regimen, relapsed/refractory acute myeloid leukemia, salvage therapy

Relation: https://figshare.com/articles/dataset/DataSheet_1_A_Phase_II_Trial_of_the_Double_Epigenetic_Priming_Regimen_Including_Chidamide_and_Decitabine_for_Relapsed_Refractory_Acute_Myeloid_Leukemia_docx/16565673

الاتاحة: https://doi.org/10.3389/fonc.2021.726926.s001